Trial Profile
A Pharmacokinetics Profile Determination of BG00012 Standard Formulation and the BG00012 Active Pharmaceutical Ingredient (API) After a Single Oral Dose Administered to Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Jun 2015
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Biogen Idec
- 21 Feb 2010 New trial record